Bactroban shortage alert

Manufacturing issues lead to shortage of popular impetigo remedy

The TGA is advising health professionals and consumers that there is a shortage of Bactroban (mupirocin) 20 mg/g ointment tubes.

Bactroban 20 mg/g ointment is used for the topical treatment of mild impetigo.

The product’s sponsor, GlaxoSmithKline Australia, has advised the TGA that the shortage is related to manufacturing issues and product is expected to be available again after 31 October 2016.

An alternative supply has been arranged with the TGA approval of a section 19A for the import and supply of a UK product, Mupirocin 20 mg/g ointment tube.

Pharmacies can obtain Mupirocin 20 mg/g ointment tubes by contacting Medsurge by phone (1300 788 261) or email

For more information, click here.


Previous Give pharmacy the power
Next Former Sigma CEO sentenced

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.


  1. Margaret Topp

    Why did this take so long for action to be taken? How many patients were treated with alternative antibiotics which then became in short supply? Not really good enough. As pharmacists we can notify TGA of shortages, and we should do so, as manufacturer notification is voluntary.

  2. PharmOwner

    I wonder how much MedSurge are charging for their mupirocin. For other products they charge like wounded bulls due to high “import costs”

Leave a reply